Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Henry Schein 3.458, Abbott Laboratories 12.593.
Henry Schein vs Abbott Laboratories Net Worth and Market Cap
Henry Schein (HSIC) and Abbott Laboratories (ABT) are peers in Healthcare. Henry Schein reported revenue of $3.5B as of Q2 2026, compared with $12.6B for Abbott Laboratories. Abbott Laboratories leads on revenue.
Henry Schein's gross margin is 31.8% versus 58.0% for Abbott Laboratories. Henry Schein's net margin is 2.7% versus 7.4% for Abbott Laboratories.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Henry Schein, Abbott Laboratories.| Metric | Henry Schein | Abbott Laboratories |
|---|---|---|
| Market Cap | - | - |
| Revenue | $3.46B | $12.59B |
| Cost of Revenue | $2.36B | $5.29B |
| Gross Profit | $1.10B | $7.30B |
| Operating Income | $200.00M | $1.78B |
| Net Income | $94.00M | $928.00M |
| R&D Expense | $0 | $882.00M |
| Earnings Per Share | $0.82 | $0.53 |
| Gross Margin | 31.8% | 58.0% |
| Operating Margin | 5.8% | 14.2% |
| Net Profit Margin | 2.7% | 7.4% |
| Free Cash Flow | $196.00M | $2.89B |
| Cumulative Free Cash Flow | $9.89B | $142.48B |
| Operating Cash Flow | $242.00M | $2.49B |
| Cash & Equivalents | $157.00M | $5.10B |